FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Clarus Securities

  • Home
  •  | 
  • Tag Archives: "Clarus Securities"

Ionic Brands Announces C$20,000,000 Marketed Offering Led By Clarus Securities

Ionic Brands Announces C$20,000,000 Marketed Offering Led By Clarus Securities
April 09, 2019 (GLOBE NEWSWIRE) -- IONIC Brands Corp., (CSE: IONC) (“IONIC BRANDS” or the “Company”) is pleased to announce it has entered into an agreement with Clarus Securities Inc. (“Clarus”) as lead agent on behalf of a syndicate of agents (collectively, the “Agents”), whereby the Agents will raise up to C$20,000,000 (the “Offering”) through an offering of up to 20,000 units of the Company (the “Units”) at $1,000 per Unit (the “Issue Price”).
Read more

Ascent Industries engages Clarus Securities

Ascent Industries engages Clarus Securities
Ascent Industries engages Clarus Securities VANCOUVER, Dec. 12, 2018 /CNW/ - Ascent Industries Corp. (CSE: ASNT) ("Ascent" or the "Company") today announced that it has engaged Clarus Securities as financial advisor to explore and evaluate a broad range of strategic alternatives to strengthen its balance sheet and maximize the value of the Company. "While the Company is focused first…
Read more

Scythian Biosciences Announces Intention to Commence Normal Course Issuer Bid to Repurchase up to 5% of its Common Shares

Scythian Biosciences Announces Intention to Commence Normal Course Issuer Bid to Repurchase up to 5% of its Common Shares
TORONTO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (“Scythian” or the “Company”) (CSE:SCYB) (Frankfurt: 9SB) (OTC – Nasdaq Intl: SCCYF) announced its intention to commence a normal course issuer bid (“NCIB”), under which the Company may purchase up to 2,451,861 of the Company’s common shares, representing approximately 5% of its issued and outstanding common shares (the “Shares”). The Company is commencing the NCIB because it believes that, from time to time, the market price of its Shares may not fully reflect the underlying value of the Company’s business and future prospects. Scythian believes that, at such times, the repurchase of its Shares for cancellation represents an appropriate use of the Company’s financial resources and will enhance shareholder value.
Read more